Free Trial

Huize (HUIZ) Competitors

Huize logo
$2.05 0.00 (0.00%)
As of 01:55 PM Eastern

HUIZ vs. RDZN, ICCH, NEUE, AAME, ZBAO, HIT, FGF, OXBR, AIFU, and CNFR

Should you be buying Huize stock or one of its competitors? The main competitors of Huize include Roadzen (RDZN), ICC (ICCH), NeueHealth (NEUE), Atlantic American (AAME), Zhibao Technology (ZBAO), Health In Tech (HIT), Fundamental Global (FGF), Oxbridge Re (OXBR), AIX (AIFU), and Conifer (CNFR). These companies are all part of the "insurance" industry.

Huize vs. Its Competitors

Roadzen (NASDAQ:RDZN) and Huize (NASDAQ:HUIZ) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

Roadzen has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500. Comparatively, Huize has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.

24.7% of Roadzen shares are owned by institutional investors. 30.4% of Huize shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Huize had 7 more articles in the media than Roadzen. MarketBeat recorded 11 mentions for Huize and 4 mentions for Roadzen. Huize's average media sentiment score of 0.38 beat Roadzen's score of 0.37 indicating that Huize is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Roadzen
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Huize
1 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Roadzen currently has a consensus price target of $5.00, indicating a potential upside of 442.30%. Huize has a consensus price target of $2.30, indicating a potential upside of 12.20%. Given Roadzen's stronger consensus rating and higher possible upside, research analysts clearly believe Roadzen is more favorable than Huize.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Roadzen
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Huize
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Huize has a net margin of 1.75% compared to Roadzen's net margin of -248.79%. Huize's return on equity of 5.07% beat Roadzen's return on equity.

Company Net Margins Return on Equity Return on Assets
Roadzen-248.79% N/A -269.99%
Huize 1.75%5.07%2.16%

Huize has higher revenue and earnings than Roadzen. Huize is trading at a lower price-to-earnings ratio than Roadzen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Roadzen$42.89M1.60-$99.67M-$1.51-0.61
Huize$1.25B0.02$9.89M-$0.42-4.88

Huize received 3 more outperform votes than Roadzen when rated by MarketBeat users. However, 100.00% of users gave Roadzen an outperform vote while only 46.15% of users gave Huize an outperform vote.

CompanyUnderperformOutperform
RoadzenOutperform Votes
3
100.00%
Underperform Votes
No Votes
HuizeOutperform Votes
6
46.15%
Underperform Votes
7
53.85%

Summary

Huize beats Roadzen on 12 of the 18 factors compared between the two stocks.

Get Huize News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUIZ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUIZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUIZ vs. The Competition

MetricHuizeInsurance agents, brokers, & service IndustryFinance SectorNASDAQ Exchange
Market Cap$20.68M$17.80B$11.72B$8.63B
Dividend YieldN/A1.68%5.66%4.18%
P/E Ratio22.7824.7323.0620.01
Price / Sales0.026.8326.95157.94
Price / Cash2.2525.6617.6034.64
Price / Book0.3519.372.894.70
Net Income$9.89M$708.45M$1.04B$248.05M
7 Day Performance8.47%-1.13%1.46%2.62%
1 Month Performance-10.48%-6.43%1.38%6.32%
1 Year Performance-91.14%-1.34%540.22%13.78%

Huize Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HUIZ
Huize
1.9181 of 5 stars
$2.05
flat
$2.30
+12.2%
-91.4%$20.68M$1.25B22.781,640Earnings Report
Analyst Downgrade
RDZN
Roadzen
1.8655 of 5 stars
$1.02
-1.9%
$5.00
+390.2%
-62.4%$75.78M$42.89M-0.68324
ICCH
ICC
N/A$23.49
flat
N/AN/A$73.74M$93.57M10.5890
NEUE
NeueHealth
1.5491 of 5 stars
$6.77
flat
$7.00
+3.4%
+21.0%$60.44M$907.35M-0.131,252Short Interest ↓
AAME
Atlantic American
2.2858 of 5 stars
$1.76
+2.3%
N/A+0.6%$35.90M$191.36M-5.03140Positive News
Short Interest ↓
ZBAO
Zhibao Technology
N/A$1.10
+8.8%
N/A-77.2%$34.65M$245.79M0.00148Positive News
Short Interest ↓
High Trading Volume
HIT
Health In Tech
N/A$0.62
-1.6%
N/AN/A$34.44M$22.38M0.0079
FGF
Fundamental Global
2.0274 of 5 stars
$16.38
-3.0%
N/A-38.4%$20.84M$13.26M12.509Positive News
Gap Up
OXBR
Oxbridge Re
3.1055 of 5 stars
$1.68
-1.8%
$5.00
+197.6%
-24.7%$12.50M$1.36M-2.003Positive News
Short Interest ↓
AIFU
AIX
N/A$3.37
+8.4%
N/AN/A$9.76M$1.81B4.625,780
CNFR
Conifer
2.5183 of 5 stars
$0.74
-1.8%
N/A-22.6%$9.07M$59.15M0.31150Short Interest ↓

Related Companies and Tools


This page (NASDAQ:HUIZ) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners